116 related articles for article (PubMed ID: 2962158)
1. [Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine].
Bergerat JP; Dufour P; Soyer Y; Bollack C; Jacqmin D; Prevot G; Juraschek F; Bailly G; de Garis S; Lang JM
Presse Med; 1987 Nov; 16(39):1953-6. PubMed ID: 2962158
[TBL] [Abstract][Full Text] [Related]
2. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma.
Rizzo M; Bartoletti R; Selli C; Sicignano A; Criscuolo D
Eur Urol; 1989; 16(4):271-7. PubMed ID: 2670581
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study.
Fosså SD; Raabe N; Moe B
Br J Urol; 1989 Nov; 64(5):468-71. PubMed ID: 2611615
[TBL] [Abstract][Full Text] [Related]
5. Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma.
Sertoli MR; Brunetti I; Ardizzoni A; Falcone A; Guarneri D; Boccardo F; Martorana G; Curotto A; Sicignano A; Rosso R
Am J Clin Oncol; 1989 Feb; 12(1):43-5. PubMed ID: 2492141
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
Otto U; Schneider A; Denkhaus H; Conrad S
Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.
Schornagel JH; Verweij J; ten Bokkel Huinink WW; Klijn JG; de Mulder PH; Debruyne FM; van Deijk WA; Roozendaal K; Kok TC; Veenhof KH
J Urol; 1989 Aug; 142(2 Pt 1):253-6. PubMed ID: 2746739
[TBL] [Abstract][Full Text] [Related]
8. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].
Cocimano V; Marino G; Brigato R; Cevoli R; Griffa D
Minerva Urol Nefrol; 1989; 41(3):187-9. PubMed ID: 2617374
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
Kellokumpu-Lehtinen P; Nordman E
J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
[TBL] [Abstract][Full Text] [Related]
11. Combination of recombinant interferon alpha-2A and vinblastine in advanced renal cell cancer.
Schuster D; Schneider G; Ade N; Heim ME
Onkologie; 1990 Oct; 13(5):359-62. PubMed ID: 2082231
[TBL] [Abstract][Full Text] [Related]
12. Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: a progress report.
Fosså SD; De Garis ST
Int J Cancer Suppl; 1987; 1():36-40. PubMed ID: 3476476
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma.
Kriegmair M; Oberneder R; Hofstetter A
Urology; 1995 May; 45(5):758-62. PubMed ID: 7747370
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
Buzaid AC; Robertone A; Kisala C; Salmon SE
J Clin Oncol; 1987 Jul; 5(7):1083-9. PubMed ID: 3598612
[TBL] [Abstract][Full Text] [Related]
15. Metastatic renal cell cancer treated with recombinant alpha 2a interferon and vinblastine.
Massidda B; Migliari R; Padovani A; Scarpa RM; Pellegrini P; Cortesi E; Usai E; Pellegrini A
J Chemother; 1991 Dec; 3(6):387-9. PubMed ID: 1819623
[TBL] [Abstract][Full Text] [Related]
16. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
Bergerat JP; Ford J; Herbrecht R; Dufour P; Oberling F; Jacqmin D; Bollack C; Prevot G; Salze P; Jurascheck F
Prog Clin Biol Res; 1990; 348():137-50. PubMed ID: 2385604
[No Abstract] [Full Text] [Related]
17. Combined interferon and vinblastine treatment of advanced melanoma and renal cell cancer.
Kellokumpu-Lehtinen P; Nordman E
Cancer Detect Prev; 1988; 12(1-6):523-9. PubMed ID: 3180144
[TBL] [Abstract][Full Text] [Related]
18. Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
Merimsky O; Shnider BI; Chaitchik S
Mol Biother; 1991 Mar; 3(1):34-7. PubMed ID: 2069758
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
Quesada JR; Evans L; Saks SR; Gutterman JU
J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
[TBL] [Abstract][Full Text] [Related]
20. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]